LINDSEY SOLAR: Open Payments
NPI 1548734932 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 39 payments from 16 companies in 2025. Trend: 2023 $406 · 2024 $911 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $228 |
| Bard Peripheral Vascular, Inc. | 4 | $129 |
| Edwards Lifesciences Corporation | 2 | $65 |
| Boston Scientific Corporation | 3 | $63 |
| Amgen Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $22 |
Products named: LEQVIO, REPATHA, VERQUVO, Venovo, EVKEEZA, WATCHMAN FLX, CARDIOMEMS, ELIQUIS.
Industry payments across LA — which companies pay providers there.
